✦ LIBER ✦

Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies

✍ Scribed by Joan H. Schiller; Barry Storer; Rhoda Arzoomanian; Kendra Tutsch; Dona Alberti; David Spriggs

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 806 KB
Volume: 11
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874427

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of dexverapamil, epirub

Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage–colony stimulating factor in patients with advanced pancreatic adenocarcinoma

✍ Gabriela Kornek; Markus Raderer; Thomas Schenk; Johann Pidlich; Franz Schulz; Se 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

A phase I trial of intraperitoneal carbo

A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies

✍ Edward F. McClay; Patricia D. Braly; Saeeda Kirmani; Steven C. Plaxe; Mary Eilee 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Granulocyte-Macrophage colony stimulatin

Granulocyte-Macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia

✍ Paul S. Frenette; Jane F. Desforges; David P. Schenkein; Arthur Rabson; Christop 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

Phase I study of escalating doses of mit

Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support

✍ Gini F. Fleming; Linda Janisch; Nicholas J. Vogelzang; Everett E. Vokes; Mark J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 2 views

## BACKGROUND. Both paclitaxel and mitoxantrone demonstrate significant antineoplastic activity in breast cancer patients. Colony stimulating factor support allows significant dose escalation of each of these drugs when administered as a single agent. ## METHODS. We performed a Phase I study empl

Improvement of pneumonia and arthritis i

Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)

✍ Lübbe, A. S. ;Schwella, N. ;Riess, H. ;Huhn, D. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 198 KB

Phase II trial of subcutaneously adminis

Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma

✍ Edward Wos; Thomas Olencki; Laurie Tuason; G. Thomas Budd; David Peereboom; Kate 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 2 views

## BACKGROUND. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that is involved in the differentiation and proliferation of various hematopoietic precursors. It also has been reported to enhance the antitumor activity of various mature effector cells. Previous reports have